type 1 papillary renal cell carcinoma

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting
  • Locally Advanced Papillary Renal Cell Carcinoma
  • +6 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +596 more
Aug 2, 2022

Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia

Completed
  • Adult Acute Myeloid Leukemia in Remission
  • +29 more
  • Fludarabine Phosphate
  • +5 more
  • Tucson, Arizona
  • +9 more
Dec 18, 2019

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +44 more
  • fludarabine phosphate
  • +9 more
  • Duarte, California
  • +6 more
Sep 6, 2019

Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib

Completed
  • Recurrent Renal Cell Carcinoma
  • +4 more
  • Erlotinib Hydrochloride
  • +2 more
  • Tucson, Arizona
  • +213 more
Dec 12, 2018

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United

Completed
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Anti-Endoglin Chimeric Monoclonal Antibody TRC105
  • +3 more
  • Duarte, California
  • +29 more
Jul 30, 2018